Amy Abernethy, MD, PhD, named FDA Principal Deputy Commissioner of Food and Drugs
Amy Abernethy, MD, PhD, adjunct professor of medicine (Medical Oncology) and a Duke University School of Medicine alumna, has been appointed the FDA’s new principal deputy commissioner of food and drugs. Her appointment will begin early next year.
Internal Medicine Residency News, Dec. 17, 2018
Catch up with the Duke Internal Medicine Residency Program by reading the weekly newsletter for Dec. 17, 2018.
2018 GIM Holiday Celebration Recap + Photo Gallery
The division of General Internal Medicine gathered at the Sarah P. Duke Gardens to celebrate the holiday season
Faculty Spotlight: Azalea Kim, MD
We were delighted to receive this interview with Dr. Azalea Kim, a new DGIM faculty member in 2018.
Internal Medicine Residency News, Dec. 10, 2018
Catch up with the Duke Internal Medicine Residency Program by reading the weekly newsletter for Dec. 10, 2018.
DGIM holiday celebration 2018
Oh what fun, the DGIM holiday celebration is this week! You don't want to miss it!
The celebration will take place this Thursday, December 13th from 4:30-7:30 PM.
GIM Journal Club: Asprin for Primary Prevention in Diabetes
The Duke Division of General Internal Medicine journal club met December 4th at the home of GIM Assistant Professor,
Daubert receives collaborative grant for study of the postpartum care received by pregnant women with hypertensive disorders
Melissa Daubert, MD, assistant professor of medicine (Cardiology), has received one of four 2018 Carolinas Collaborative Grant awards to examine the postpartum care received by pregnant women with hypertensive disorders.
Duke Study Finds Expanded Cord Blood Shows Potential for Use in Adult Bone Marrow Transplants
A study led by Mitchell Horwitz, MD, professor of medicine (Hematologic Malignancies and Cellular Therapy), has found that umbilical cord blood stem cells that are cultured and expanded outside the body before being used for bone marrow transplant in adult blood cancer patients appear safe and restore blood count recovery faster than standard cord blood. The findings advance efforts to improve cord blood use among adults who have been diagnosed with blood cancers.